Exelon Corporation (NYSE:EXC) belongs to Utilities sector. Its net profit margin is 8.00% and weekly performance is -1.56%. On last trading day company shares ended up $33.42. The Delaware Public Service Commission (PSC) today issued an order approving the merger between Exelon Corporation (NYSE:EXC) and Pepco Holdings Inc. (NYSE: POM) upon the terms set forth in the parties’ application, as amended by the Amended Settlement Agreement filed with the PSC on April 7, 2015. This action follows the Commission’s deliberations on May 19, 2015, when the Commission voted to approve the Amended Settlement Agreement.
CareDx, Inc (NASDAQ:CDNA) shares moved up 8.82% in last trading session and ended the day at $5.55. CDNA Gross Margin is 68.20% and its return on assets is -0.40%. CareDx, Inc (NASDAQ:CDNA) quarterly performance is -11.90%. CareDx, Inc (NASDAQ:CDNA), announced they have entered into a collaboration to develop cell-free DNA (cfDNA) reference standards. These HDx™ Reference standards, being developed by Horizon Diagnostics, a division of Horizon, will support proficiency testing of CareDx’s solid organ transplant injury monitoring diagnostic tests and will be integrated into CLIA laboratory testing.
Synopsys Inc. (NASDAQ:SNPS) belongs to Technology sector. Its net profit margin is 11.50% and weekly performance is 1.46%. On last trading day company shares ended up $50.73. Synopsys Inc. (NASDAQ:SNPS) distance from 50-day simple moving average (SMA50) is 6.35%. TowerJazz, TowerJazz Panasonic Semiconductor Co., Ltd. or TPSCo and Synopsys, Inc. (NASDAQ:SNPS), have qualified a 65 nanometer CMOS image sensor or CIS interoperable process design kit to allow customers to design and develop new products using Synopsys’ custom design solution.
RAIT Financial Trust (NYSE:RAS) ended the last trading day at $6.40. Company weekly volatility is calculated as 1.67% and price to cash ratio as 5.72. RAIT Financial Trust (NYSE:RAS) showed a weekly performance of -0.78%. Zacks cut shares of RAIT Financial Trust (NYSE:RAS) from a hold rating to a sell rating in a research note issued to investors on Monday.
TherapeuticsMD, Inc. (NYSEMKT:TXMD) shares moved up 5.54% in last trading session and ended the day at $7.62. TXMD Gross Margin is 76.60% and its return on assets is -95.00%. TherapeuticsMD, Inc. (NYSEMKT:TXMD) quarterly performance is 44.05%. TherapeuticsMD, Inc. (NYSEMKT:TXMD) announced CEO Robert G. Finizio will provide an overview of the company at Goldman Sachs 36th Annual Global Healthcare Conference, Tuesday, June 9 at 9:20 a.m. PDT at the Terranea Resort in Rancho Palos Verdes, Calif.